Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ARTL
#9739
Artelo Biosciences, Inc. Common Stock
3.760
0
USD
-3.59%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
-3.59%
Mudança mensal
+213.33%
Mudança em 6 meses
+213.33%
Mudança anual
+213.33%
Fechamento anterior
3.900
0
Open
3.760
0
Bid
3.760
0
Ask
3.763
0
Low
3.760
0
High
3.760
0
Volume
1
Mercados
Ações
Cuidados de saúde
ARTL
Open full chart
Financials
Overview
Relatórios
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
537.95 K
546.84 K
546.84 K
1.32 M
2.02 M
2.12 M
—
Valuation ratios
Enterprise value
—
—
—
17.29 M
7.3 M
1.99 M
—
Price to earnings ratio
—
—
—
-0.7
-0.22
-0.1
—
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
1.32
0.35
0.15
—
Price to book ratio
—
—
—
0.64
0.47
0.99
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.8
0.67
0.74
0.73
1.49
3.63
Return on equity %
0.18
1.32
3.64
2.29
4.93
3.28
14.13
Return on invested capital %
115.86
357.6
366.21
464.69
384.5
340.43
1 555.83
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.15
1.44
0.49
0.39
0.38
0.17
1.43
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
0.18
0.21
0.16
—
Long term debt to total equity ratio
—
—
—
0.56
1.38
0.34
—
Per share metrics
Operating cash flow per share
1.45
4.78
2.92
0.9
4.44
2.83
11.09
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.39
0.47
1.74
0.44
2.5
0.58
5.26
Net current asset value per share
9.27
4.76
2.53
3.89
2.32
0.68
9.41
Tangible book value per share
8.03
1.52
-2.54
-1.1
-1.79
-0.75
-6.17
Working capital per share
7.97
1.46
-2.6
-6.06
-3.85
-3.25
-15.77
Book value per share
11.82
5.32
1.19
2.45
0.8
1.24
5.68
Notícias
Artelo Biosciences implementa grupamento de ações de 3 por 1
Artelo Biosciences implements 3-for-1 reverse stock split
Artelo Biosciences reporta prejuízo de US$ 12,9 milhões em 2025
Artelo Biosciences reports $12.9M loss for 2025
Artelo Biosciences adia assembleia anual por falta de quórum
Artelo Biosciences adjourns annual meeting due to lack of quorum
White House launches Medicare pilot program for CBD reimbursement
Inibidor FABP5 da Artelo mostra resultados promissores para ansiedade e depressão
Artelo’s FABP5 inhibitor shows promise for anxiety and depression
Artelo Biosciences nomeia Mark Spring como novo CFO
Artelo Biosciences appoints Mark Spring as new CFO
Artelo Biosciences nomeia Mark Spring como CFO e altera acordos executivos